The COVID-RASi Trial (COVID-19)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,155

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
COVID-19Cardiovascular Diseases
Interventions
DRUG

Angiotensin converting enzyme inhibitor

The study recommends physicians to select an ACEi with proven benefit in cardiovascular diseases such as perindopril, ramipril or enalapril. Lab values will be obtained during baseline. The patient will be followed by the physician clinically, with recommended laboratory testing in one week, including renal function, potassium assessment, and dose adjustments as appropriate.

DRUG

Angiotensin II Receptor Blockers

The study recommends physicians to select evidence-based ARBs such as candesartan or valsartan or losartan. Lab values will be obtained during baseline. The patient will be followed by the physician clinically, with recommended laboratory testing in one week, and dose adjustments as appropriate.

Trial Locations (31)

72560

Hospital General de Zona 20, La Margarita

76269

Hospital General Regional No 2, El Marqués

91000

Hospital General zona 11, Xalapa

Unidad de Medicina Familiar No 10, Xalapa

Unknown

Centro de Pesquisa Clinicas Dr Marco Mota, Maceió

Santa Casa de Itabuna, Itabuna

Hospital Felicio Rocho, Belo Horizonte

Centro de Pesquisa Clinica da Unimed Campo Grande, Campo Grande

Clinica de Campo Grande, Campo Grande

Hospital Agamenom Magalhaes, Recife

Pronto Socorro Cardiologico de Pernambuco Recife, Recife

Instituto Atena de Pesquisa Clinica, Natal

Hospital Universitar Canoas, Canoas

Hospital Sao Vicente de Paulo, Passo Fundo

Instituto de Pesquisa Clinica de Campinas, Campinas

Hospital Bela Vista, Consolação

Instituto de Coracao, São Paulo

Instituto Prevent Senior, São Paulo

Instituto Goiano de Oncologia e Hematologia, Goiânia

Alberta Health Services, Edmonton

University of Ottawa Heart Institute, Ottawa

Unidad de Medicina Familiar No 77, Ecatepec de Morelos

Hospital General 1, IMSS, Mexico City

Hospital General de zona 27- IMSS, Mexico City

60-430-350

Centro de Pesquisas em Diabetes e Doencas Endocrino-Metabolicas, Fortaleza

80730-150

Nucleo de Pesquisa Clinica SS, Curitiba

50870-901

Hospital Eduardo Campos da Pessoa Idosa, Estância

90610-000

Hospital Sao Lucas da PUCRS, Porto Alegre

12916-542

Hospital Universitario Sao Francisco na Providencia de Deus, Bragança Paulista

01409-901

Hospital de Julho, São Paulo

06900

Hospital de Infectologia Dr Daniel Mendez Fernandez, Azcapotzalco

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER